189 related articles for article (PubMed ID: 25033707)
1. The prognostic value of liver tumor T cell infiltrates.
Khan H; Pillarisetty VG; Katz SC
J Surg Res; 2014 Sep; 191(1):189-95. PubMed ID: 25033707
[TBL] [Abstract][Full Text] [Related]
2. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between TIL from human primary hepatic carcinoma and prognosis].
Qin J; Han B; Pang J
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):167-70. PubMed ID: 9596951
[TBL] [Abstract][Full Text] [Related]
4. Memory T-lymphocytes are the main population of tumor-infiltrating lymphocytes obtained from human primary liver tumors.
Shimizu Y; Watanabe A; Whiteside TL
J Hepatol; 1992 Sep; 16(1-2):197-202. PubMed ID: 1484153
[TBL] [Abstract][Full Text] [Related]
5. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy.
Lo CS; Sanii S; Kroeger DR; Milne K; Talhouk A; Chiu DS; Rahimi K; Shaw PA; Clarke BA; Nelson BH
Clin Cancer Res; 2017 Feb; 23(4):925-934. PubMed ID: 27601594
[No Abstract] [Full Text] [Related]
7. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.
Hiraoka N
Int J Clin Oncol; 2010 Dec; 15(6):544-51. PubMed ID: 20924634
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes
Wang WC; Zhang ZQ; Li PP; Ma JY; Chen L; Qian HH; Shi LH; Yin ZF; Sun B; Zhang XF
Cancer Biol Ther; 2019; 20(9):1187-1194. PubMed ID: 31018748
[No Abstract] [Full Text] [Related]
9. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
Front Immunol; 2020; 11():2105. PubMed ID: 33013886
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.
Ma D; Niederkorn JY
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016
[TBL] [Abstract][Full Text] [Related]
11. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.
Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN
Front Immunol; 2021; 12():731329. PubMed ID: 35069521
[TBL] [Abstract][Full Text] [Related]
13. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Immunol Immunother; 1991; 32(5):280-8. PubMed ID: 1847844
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression in liver tumors: opening the portal to effective immunotherapy.
Guha P; Reha J; Katz SC
Cancer Gene Ther; 2017 Mar; 24(3):114-120. PubMed ID: 27910858
[TBL] [Abstract][Full Text] [Related]
15. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
16. Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.
Wouters MC; Komdeur FL; Workel HH; Klip HG; Plat A; Kooi NM; Wisman GB; Mourits MJ; Arts HJ; Oonk MH; Yigit R; de Jong S; Melief CJ; Hollema H; Duiker EW; Daemen T; de Bruyn M; Nijman HW
Clin Cancer Res; 2016 Feb; 22(3):714-24. PubMed ID: 26384738
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism.
Zhu J; Petit PF; Van den Eynde BJ
Cancer Immunol Immunother; 2019 May; 68(5):835-847. PubMed ID: 30406374
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma.
Kawata A; Une Y; Hosokawa M; Uchino J; Kobayashi H
Jpn J Clin Oncol; 1992 Aug; 22(4):256-63. PubMed ID: 1331571
[TBL] [Abstract][Full Text] [Related]
19. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.
Braun MW; Abdelhakim H; Li M; Hyter S; Pessetto Z; Koestler DC; Pathak HB; Dunavin N; Godwin AK
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33037114
[TBL] [Abstract][Full Text] [Related]
20. Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.
Ripley RT; Davis JL; Klapper JA; Mathur A; Kammula U; Royal RE; Yang JC; Sherry RM; Hughes MS; Libutti SK; White DE; Steinberg SM; Dudley ME; Rosenberg SA; Avital I
Ann Surg Oncol; 2010 Jan; 17(1):163-70. PubMed ID: 19777192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
